Stock Events

Stock Events

Insulet 

$163.26
143
+$4.88+3.08% Friday 20:00
-$1.26-0.77%Friday 23:34After hours

Statistics

Day High
163.39
Day Low
163.26
52W High
354.88
52W Low
138.79
Volume
51,922
Avg. Volume
-
Mkt Cap
11.31B
P/E Ratio
37.77
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.79
1.04
1.3
1.55
Expected EPS
1.452347
Actual EPS
N/A

Financials

9.12%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.71BRevenue
247.1MNet Income

Analyst Ratings

229.94Average Price Target
The highest estimate is 360.00.
From 18 ratings within the last 6 months. This is not an investment recommendation.
Buy
83%
Hold
11%
Sell
6%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PODD. It's not an investment recommendation.
Microsoft
40
MSFT
Amazon
39
AMZN
NVIDIA
39
NVDA
Tesla
34
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Tandem Diabetes Care
TNDM
Mkt Cap1.06B
Tandem Diabetes Care, Inc. competes directly with Insulet by offering insulin pump therapy for diabetes management, which is a direct alternative to Insulet's Omnipod system.
Medtronic
MDT
Mkt Cap107.36B
Medtronic plc is a major competitor in the insulin pump market, offering a range of products that compete with Insulet's offerings for diabetes management.
Dexcom
DXCM
Mkt Cap28.93B
DexCom, Inc. provides continuous glucose monitoring (CGM) systems that are often used in conjunction with insulin pumps like those offered by Insulet, making them a competitor in the broader diabetes management space.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories offers the FreeStyle Libre, a CGM system that competes with the integrated diabetes management solutions provided by Insulet.
Insulet
PODD
Mkt Cap11.17B
Insulet Corporation is listed as its own competitor due to an error. Please disregard this entry.
Senseonics
SENS
Mkt Cap280.85M
Senseonics Holdings, Inc. offers the Eversense CGM system, which competes in the diabetes management market by providing an alternative to the CGM solutions that can be used with Insulet's products.
Novo Nordisk
NVO
Mkt Cap218.94B
Novo Nordisk A/S is a leading provider of insulin and other diabetes care products that, while not a direct competitor in the insulin pump market, competes in the broader diabetes management space.
Sanofi
SNY
Mkt Cap104.13B
Sanofi provides a range of diabetes care solutions, including insulin therapies that compete with the insulin management solutions offered by Insulet.
Mannkind
MNKD
Mkt Cap1.26B
MannKind Corporation offers Afrezza, an inhaled insulin, providing a non-injectable alternative to insulin delivery that competes with traditional pump therapies like those offered by Insulet.

About

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Show more...
CEO
Ms. Ashley A. McEvoy
Employees
5400
Country
United States
ISIN
US45784P1012

Listings

MI
IT
1PODD.MI
LSE
GB
0ADR.LSE
XETRA
DE
GOV.XETRA
STU
DE
GOV.STU

0 Comments

Share your thoughts

FAQ

What is Insulet stock price today?▼
The current price of PODD is $163.26 USD — it has increased by +3.08% in the past 24 hours. Watch Insulet stock price performance more closely on the chart.
What is Insulet stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Insulet stocks are traded under the ticker PODD.
Is Insulet stock price growing?▼
PODD stock has fallen by -0.49% compared to the previous week, the month change is a +3.17% rise, over the last year Insulet has showed a -43.75% decrease.
What is Insulet market cap?▼
Today Insulet has the market capitalization of 11.31B
When is the next Insulet earnings date?▼
Insulet is going to release the next earnings report on August 05, 2026.
What were Insulet earnings last quarter?▼
PODD earnings for the last quarter are 1.42 USD per share, whereas the estimation was 1.2 USD resulting in a +18.46% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Insulet revenue for the last year?▼
Insulet revenue for the last year amounts to 2.71B USD.
What is Insulet net income for the last year?▼
PODD net income for the last year is 247.1M USD.
How many employees does Insulet have?▼
As of July 26, 2026, the company has 5,400 employees.
In which sector is Insulet located?▼
Insulet operates in the Health & Wellness sector.
When did Insulet complete a stock split?▼
Insulet has not had any recent stock splits.
Where is Insulet headquartered?▼
Insulet is headquartered in Acton, United States.